We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

In this piece, we will look at where Moderna, Inc. (NASDAQ:MRNA) sits on the fund managers’ radar. The surge in interest ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack ...

During the COVID pandemic, many of us received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for ...

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

Dr Patrick Moore, the study's chief investigator and the National Institute for Health and Care Research (NIHR) director in ...

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...